BioPharm America™ 2016: Cloud computing is the secret to Cloud Pharmaceuticals' drug discovery

September 30, 2016
Cloud Pharmaceuticals COO Don Van Dyke speaks with Informa Pharma Intelligence at BioPharm America 2016 about how the company uses cloud computing to accelerate the discovery and design of novel small-molecule drug candidates in therapeutic areas such as cancer, inflammatory disease, infectious disease and central nervous system disorders. Van Dyke discusses how an ongoing partnership helped Cloud develop its technology for creating drug candidates that can pervade the blood-brain barrier and the company's virtual model, in which it performs the computational chemistry and partners out bench preclinical processes.
Previous Video
BioPharm America™ 2016: ContraVir conducting Phase II studies for combination therapy in HBV
BioPharm America™ 2016: ContraVir conducting Phase II studies for combination therapy in HBV

ContraVir CEO James Sapirstein talked with Informa Pharma Intelligence at BioPharm America 2016 about his c...

Next Video
BioPharm America™ 2016: Novel approach to CAR T cell therapy at UPenn Center for Cellular Immunotherapies
BioPharm America™ 2016: Novel approach to CAR T cell therapy at UPenn Center for Cellular Immunotherapies

Avery Posey, Instructor at the Center for Cellular Immunotherapies at the University of Pennsylvania is int...